Crossref
Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension
Circulation · 2023
DOI: 10.1161/circulationaha.123.064318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2023. Verfasst von Bertram Pitt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Michigan School of Medicine, Ann Arbor (B.P.). Hauptthemen laut MEDLINE: Aldosterone, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AldosteroneHypertensionHumansReceptors, MineralocorticoidMineralocorticoid Receptor Antagonists
Stichwörter der Autor:innen
aldosteronehypertensionmineralocorticoid receptor
Substanzen
AldosteroneReceptors, MineralocorticoidMineralocorticoid Receptor Antagonists
Autor:innen und Institutionen
- Division of Cardiology, University of Michigan School of Medicine, Ann Arbor (B.P.).
- Center for Adrenal Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.V.).
ORCID-Profile: Anand Vaidya
Zitieren
APA
Pitt, B., & Vaidya, A. (2023). Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension. Circulation. https://doi.org/10.1161/circulationaha.123.064318
Vancouver
Pitt B, Vaidya A. Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension. Circulation. 2023. doi:10.1161/circulationaha.123.064318
BibTeX
@article{Pitt2023,
author = {Pitt, Bertram and Vaidya, Anand},
title = {Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension},
journal = {Circulation},
year = {2023},
doi = {10.1161/circulationaha.123.064318}
}
EUVIMED